Treating type 2 diabetes. It is used along with diet and exercise. Bydureon is a glucagon-like peptide-1 (GLP-1) receptor agonist. It lowers blood sugar by increasing the release of insulin from the pancreas. It also mimics the actions of certain hormones that lower blood sugar levels.
Bydureon is an injectable drug that helps in controlling blood sugar levels in diabetic patients. Bydureon assists a patient's pancreas to efficiently produce insulin. The drug is used in the treatment of type 2 diabetes and is an extended-release form of exenatide. In treating type 2 diabetes, Bydureon is used with support of exercise and diet. Bydureon belongs to incretin mimetics and assists the pancreas to release insulin when the sugar levels are high in the blood. The drug reduces the sugar and liver products and slows down stomach emptying.
Bydureon is an injectable prescription medicine that improves blood sugar in adults with type 2 diabetes mellitus, and should be taken along with exercise and diet. Bydureon is an extended-release formulation of exenatide which is administered once every 7 days (weekly) as an injection.
Bydureon is used in the treatment of type 2 diabetes by helping control blood sugar levels. Bydureon helps your pancreas produce insulin more efficiently.
Bydureon works by helping the body release its own insulin when needed to reduce blood sugar. Bydureon has a slow continuous release formula. One dose lasts 7 days. Each dose of Bydureon is made up of tiny particles that contain the active ingredient called exenatide, which slowly break down, gradually releasing exenatide into your body throughout the week, to help control your blood sugar levels.